Bavarian Nordic AS - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Bavarian Nordic AS. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Bavarian Nordic AS. The Group's principal activities are development and production of vaccines and immune therapy products. The Group applies gene therapy and new methodologies in vaccine delivery. The Group utilises three proprietary delivery technologies for its product development programmes: a pox virus vector, a retroviral vector and a cell encapsulation technology. The main product of the Group is the manufacture of smallpox vaccine. The ongoing clinical programmes involve HIV, malignant melanoma, smallpox and cancer research. The Group operates in Denmark, Germany, the US and Singapore.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report